Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cardiovascular Surgical Experiences of Ivc Tumor and Thrombus: Operative Strategies Based on 51 Consecutive Patients Publisher Pubmed



Rahmanian M1 ; Badkoubeh RS2 ; Rasouli SJ3 ; Nowroozi MR3 ; Saberi K4 ; Salehi M4 ; Larti F2 ; Tajaddini A5 ; Fatemian H6 ; Rad MR7 ; Dabaghi GG7 ; Malekhosseini H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiovascular Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran
  2. 2. Department of Cardiology, Tehran University of Medical Science, Tehran, Iran
  3. 3. Uro-Oncology Research Center, Tehran University of Medical Science, Tehran, Iran
  4. 4. Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran
  5. 5. Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
  7. 7. School of Medicine, Isfahan University of Medical Science, Isfahan, Iran

Source: Asian Cardiovascular and Thoracic Annals Published:2023


Abstract

Background: The only beneficial treatment option for the management of inferior vena cava (IVC) tumor thrombus is complete tumor removal. The aim of this study was to report our experience in surgical and clinical outcomes in patients with tumor thrombosis in IVC. Methods: A retrospective chart review of patients who underwent surgical resection of IVC tumor at our institution over the past 10 years was performed. The patients were identified using a prospectively maintained database. Results: We identified 51 patients, the mean age was 53.4 ± 16.8 years, and 25.4% were female. They were divided into three groups based on tumor thrombosis level. Twenty patients (39.2%) required sternotomy, and cardiopulmonary bypass (CPB) was used in 19 (37.2%) patients, and 2 (3.9%) cases underwent coronary artery bypass graft. The perioperative complications were severe bleeding (3 patients), pulmonary embolism (2 patients), and duodenal perforation (1 patient). Three (5.8%) in-hospital deaths occurred, and all were due to severe abdominal bleeding. After a mean follow-up time of 46.5 ± 42.0 months, 29 (56.9%) patients were alive. The mean survival time was 75.2 ± 8.4 months. In multivariate analysis, higher age (p = 0.033) and male gender (p = 0.033) proved to be independent prognostic factors. Conclusions: Tumor thrombus extending to the IVC is a rare and challenging event. Although using CPB may be safe and result in long-term survival with acceptable function, excessive bleeding during surgery may limit the use of this method. © The Author(s) 2023.